These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 22392809)

  • 1. Perspectives on the discovery of small-molecule modulators for epigenetic processes.
    Lu Q; Quinn AM; Patel MP; Semus SF; Graves AP; Bandyopadhyay D; Pope AJ; Thrall SH
    J Biomol Screen; 2012 Jun; 17(5):555-71. PubMed ID: 22392809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibitors of histone acetyltransferases as epigenetic tools and drug candidates.
    Furdas SD; Kannan S; Sippl W; Jung M
    Arch Pharm (Weinheim); 2012 Jan; 345(1):7-21. PubMed ID: 22234972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current trends in epigenetic drug discovery.
    Stolfa DA; Einsle O; Sippl W; Jung M
    Future Med Chem; 2012 Oct; 4(16):2029-37. PubMed ID: 23157236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential.
    Bayo J; Dalvi MP; Martinez ED
    Future Med Chem; 2015; 7(16):2243-61. PubMed ID: 26510529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An efficient high-throughput screening method for MYST family acetyltransferases, a new class of epigenetic drug targets.
    Falk H; Connor T; Yang H; Loft KJ; Alcindor JL; Nikolakopoulos G; Surjadi RN; Bentley JD; Hattarki MK; Dolezal O; Murphy JM; Monahan BJ; Peat TS; Thomas T; Baell JB; Parisot JP; Street IP
    J Biomol Screen; 2011 Dec; 16(10):1196-205. PubMed ID: 22086725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic small molecule modulators of histone and DNA methylation.
    Hauser AT; Robaa D; Jung M
    Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview.
    Eglen RM; Reisine T
    J Biomol Screen; 2011 Dec; 16(10):1137-52. PubMed ID: 22002420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for inhibitors of low-affinity epigenetic peptide-protein interactions: an AlphaScreen-based assay for antagonists of methyl-lysine binding proteins.
    Wigle TJ; Herold JM; Senisterra GA; Vedadi M; Kireev DB; Arrowsmith CH; Frye SV; Janzen WP
    J Biomol Screen; 2010 Jan; 15(1):62-71. PubMed ID: 20008125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in the discovery of small-molecule inhibitors of bromodomain--histone interactions.
    Chung CW; Witherington J
    J Biomol Screen; 2011 Dec; 16(10):1170-85. PubMed ID: 21956175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic assays for chemical biology and drug discovery.
    Gul S
    Clin Epigenetics; 2017; 9():41. PubMed ID: 28439316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and classes of epigenetic drugs for cancer.
    Dhanak D; Jackson P
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):58-69. PubMed ID: 25016182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic drugs that do not target enzyme activity.
    Owen DR; Trzupek JD
    Drug Discov Today Technol; 2014 Jun; 12():e29-34. PubMed ID: 25027371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic prospects for epigenetic modulation.
    Heightman TD
    Expert Opin Ther Targets; 2011 Jun; 15(6):729-40. PubMed ID: 21366500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient hit-finding approaches for histone methyltransferases: the key parameters.
    Ahrens T; Bergner A; Sheppard D; Hafenbradl D
    J Biomol Screen; 2012 Jan; 17(1):85-98. PubMed ID: 21990582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput screening for modulators of protein-protein interactions: use of photonic crystal biosensors and complementary technologies.
    Heeres JT; Hergenrother PJ
    Chem Soc Rev; 2011 Aug; 40(8):4398-410. PubMed ID: 21140010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual screening in small molecule discovery for epigenetic targets.
    Li GB; Yang LL; Yuan Y; Zou J; Cao Y; Yang SY; Xiang R; Xiang M
    Methods; 2015 Jan; 71():158-66. PubMed ID: 25462557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic opportunities and challenges in cancer.
    Best JD; Carey N
    Drug Discov Today; 2010 Jan; 15(1-2):65-70. PubMed ID: 19897050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of biomarkers in the discovery of novel anti-schizophrenia drugs.
    Mikkelsen JD; Thomsen MS; Hansen HH; Lichota J
    Drug Discov Today; 2010 Feb; 15(3-4):137-41. PubMed ID: 20036755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.
    Parfett CL; Desaulniers D
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of homogeneous nonradioactive methyltransferase and demethylase assays targeting histone H3 lysine 4.
    Gauthier N; Caron M; Pedro L; Arcand M; Blouin J; Labonté A; Normand C; Paquet V; Rodenbrock A; Roy M; Rouleau N; Beaudet L; Padrós J; Rodriguez-Suarez R
    J Biomol Screen; 2012 Jan; 17(1):49-58. PubMed ID: 21940714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.